R&D operating model combining a small-team structure with outsourcing
First written in FY2016. 8 of 13 entries say "Advanced", first in FY2018. Latest entry: FY2026.
25 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「As of the end of the fiscal year, the company had 15 research and development employees and operated with a small workforce. By making full use of the collaborative relationships described above, however, it is efficiently and actively advancing research and development of its existing pipeline and obtaining new development candidate compounds.」
The company continues to supplement its small 15-person research and development workforce through external organizations, CROs, joint research and the SAB. - FY2024RestatedAnnual report
「As of the end of the fiscal year, the company had 11 R&D personnel and maintained a lean operating structure. By making full use of the collaborative relationships described above, it is efficiently and proactively advancing R&D for its existing pipeline and acquiring new development candidate compounds.」
The company is maintaining a lean R&D structure with 11 personnel and advancing R&D through collaboration with external institutions, CROs and joint research partners. - FY2023AdvancedAnnual report
「As of the end of the fiscal year, the company had 11 R&D personnel and maintained a lean operating structure. By making full use of the collaborative relationships described above, it is efficiently and proactively advancing R&D for its existing pipeline and acquiring new development candidate compounds.」
R&D headcount increased from 10 in the previous fiscal year to 11. The company is advancing R&D through collaboration with external institutions, CROs and joint research partners while maintaining a lean workforce. - FY2022RestatedAnnual report
「As of the end of the fiscal year, the company had 10 R&D personnel and maintained a lean operating structure. By making full use of the collaborative relationships described above, it is efficiently and proactively advancing R&D for its existing pipeline and acquiring new development candidate compounds.」
The company is maintaining a lean R&D structure with 10 personnel and advancing R&D through collaboration with external institutions, CROs and joint research partners. - FY2021AdvancedAnnual report
「As of the end of the fiscal year, the company had 10 R&D personnel and maintained a lean operating structure. By making full use of the collaborative relationships described above, it is efficiently and proactively advancing R&D for its existing pipeline and acquiring new development candidate compounds.」
R&D headcount increased from 9 previously to 10. The company continues to operate by leveraging external collaboration while maintaining a lean workforce. - FY2020Decrease in R&D headcountAnnual report
「As of the end of the fiscal year, the company had 9 R&D personnel and maintained a lean operating structure. By making full use of the collaborative relationships described above, it is efficiently and proactively advancing R&D for its existing pipeline and acquiring new development candidate compounds.」
The company continues to operate its lean R&D structure by leveraging external collaboration, but R&D headcount decreased from the previously reported 11 to 9. - FY2018AdvancedAnnual report
「As of 30 June 2018, the Company had 11 research and development personnel and operated with a small team. By making full use of the collaborative relationships described above, it was efficiently and proactively advancing research and development for its existing pipeline and acquiring new development candidate compounds.」
R&D headcount increased from 8 in the previous fiscal year to 11. The company is putting in place a more concrete framework for advancing R&D while maintaining a lean workforce and leveraging collaboration with external institutions, CROs and joint research partners. - FY2017RestatedAnnual report
「As of 30 June 2017, the Company had 8 research and development personnel and operated with a small team. By making full use of the collaborative relationships described above, it was efficiently and proactively advancing research and development for its existing pipeline and acquiring new development candidate compounds.」
The Company continues to supplement its small 8-person research and development team through outsourcing, CROs, joint research and SABs. - FY2016First statedAnnual report
「As of 30 June 2016, the Company had 11 research and development personnel and operated with a small team. By making full use of the collaborative relationships described above, it was efficiently and proactively advancing research and development for its existing pipeline and acquiring new development candidate compounds.」
The Company supplements its small 11-person research and development team through external collaboration, outsourcing and the use of CROs.